A tunable immune-evasion function of Zika virus NS5 governs viral fitness and pathogenesis
Open Access
- 20 October 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (43)
Abstract
Type I interferon (IFN) signaling is a central antiviral defense, with STAT2 driving the expression of IFN-stimulated genes (ISGs) to restrict viral infection. Zika virus (ZIKV) and dengue virus evade this pathway through nonstructural protein 5 (NS5)-mediated ubiquitination and proteasomal degradation of STAT2, yet the contribution of this immune-evasion strategy to viral fitness and pathogenesis remains incompletely defined. Here, using a multistep mutational scanning strategy that jointly assessed STAT2 degradation and viral RNA replication, we identified a single NS5 residue, L162, as uniquely permissive to substitution that abolishes STAT2 degradation without compromising intrinsic replication functions. Substitution of L162 with alanine or glycine (L162A or L162G) selectively disrupted NS5 recruitment of the ZSWIM8-CUL3 E3 ubiquitin ligase, thereby preserving STAT2 stability and restoring IFN signaling. Recombinant ZIKV carrying these mutations exhibited reduced replication and enhanced ISG induction in human cells, defects fully rescued by STAT2 knockout. In A129 mice (type I IFN receptor deficient), mutant and WT viruses replicated comparably, but in human STAT2 knock-in mice, ZIKV-NS5 L162G exhibited markedly reduced viral loads and disease. In pregnant human STAT2 knock-in mice, the mutant also reduced placental and fetal viral burdens and adverse pregnancy outcomes. Notably, infection with ZIKV-NS5 L162G elicited robust neutralizing antibody and T cell responses that conferred protection against WT challenge. Together, these findings establish NS5-mediated STAT2 degradation as a central determinant of ZIKV immune-evasion, viral fitness, and pathogenesis and highlight disruption of NS5–STAT2 antagonism as a promising strategy for antiviral intervention and rational attenuation.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2305900)
- National Natural Science Foundation of China (82241077)
- National Natural Science Foundation of China (82341084)
- National Natural Science Foundation of China (82272302)
- Tsinghua University Dushi Program (20251080029)
This publication has 70 references indexed in Scilit:
- Bibliometric analysis of flavivirus-host interactions and immune responses: Research hotspots and trendsBiosafety and Health, 2024
- A safe replication-defective Zika virus vaccine protects mice from viral infection and vertical transmissionAntiviral Research, 2023
- Assessing the risk of spread of Zika virus under current and future climate scenariosBiosafety and Health, 2022
- Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody responseClinical & Translational Immunology, 2020
- Functional Analysis of Glycosylation of Zika Virus Envelope ProteinCell Reports, 2017
- Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal DemiseCell, 2016
- Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface ExpressionCell Host & Microbe, 2015
- The Interferon Signaling Antagonist Function of Yellow Fever Virus NS5 Protein Is Activated by Type I InterferonCell Host & Microbe, 2014
- Mouse STAT2 Restricts Early Dengue Virus ReplicationCell Host & Microbe, 2010
- Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human useVaccine, 1988